Format

Send to

Choose Destination
Ann Lab Med. 2017 Jan;37(1):92-94. doi: 10.3343/alm.2017.37.1.92.

Acromicric Dysplasia Caused by a Novel Heterozygous Mutation of FBN1 and Effects of Growth Hormone Treatment.

Author information

1
Green Cross Laboratories, Yongin, Korea.
2
Department of Pediatrics, Myongji Hospital, Seonam University College of Medicine, Goyang, Korea.
3
Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
4
Department of Laboratory Medicine & Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
5
Department of Radiology, Woorisoa Children's Hospital, Seoul, Korea.
6
Department of Pediatrics, Myongji Hospital, Seonam University College of Medicine, Goyang, Korea. sjkim0128@mjh.or.kr.
PMID:
27834076
PMCID:
PMC5107629
DOI:
10.3343/alm.2017.37.1.92
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for The Korean Society for Laboratory Medicine Icon for PubMed Central
Loading ...
Support Center